Newt

Research Guide

Peptide Purity vs Identity: Why a High HPLC Percentage Is Not the Whole Test

Updated September 8, 20265 min read

When a peptide certificate of analysis shows a high purity percentage, it is tempting to treat that number as a complete quality statement. It is not. Purity and identity answer different analytical questions, and a useful COA keeps those questions separate.

Purity asks how much of the detected material fits the reporting method. Identity asks whether the evidence is consistent with the material named on the label. A batch can have a strong result for one and still require additional evidence for the other.

The short answer

Question Typical evidence What it does not establish alone
Is the material consistent with the claimed peptide? Mass spectrometry or another validated identity method Purity, sterility, potency or safety
How much of the detected signal is assigned to the main component? HPLC area percentage under a stated method Complete composition or vial quantity
How much material is in the container? Net-content or assay measurement Molecular identity or absence of impurities

What identity testing means

Identity testing compares an observed analytical signal with the expected characteristics of the claimed material. For synthetic peptides, mass spectrometry is commonly used because it can measure molecular mass or mass-to-charge signals that are compared with an expected value.

A report may show an observed mass, a theoretical mass, a spectrum, a pass/fail statement or several charged ions. The laboratory method determines how those signals should be interpreted. A reader should not select one peak and assume it proves every structural feature.

What HPLC purity means

High-performance liquid chromatography separates components under defined conditions. The reported purity may be an area percentage calculated from the integrated target peak relative to the peaks included by the method.

That percentage is method-dependent. It can be affected by the column, mobile phase, gradient, detector, sample preparation, integration rules and whether related compounds are separated or co-elute. Substances that do not respond strongly under the selected conditions may not be represented proportionally.

For that reason, 99.5% purity should be read as 99.5% by the stated method and reporting basis, not as a universal statement that 99.5% of everything in the vial has been identified.

Why both results are useful

  1. HPLC can show whether a principal chromatographic component dominates the detected signal.
  2. Mass spectrometry can support whether the observed molecular mass is consistent with the claimed material.
  3. Reviewing both against the same lot and report identifiers reduces the risk of reading an unrelated document.

Neither method automatically proves sterility, endotoxin status, biological activity, stability, safety or suitability for a particular experiment. Those attributes require their own methods and specifications when relevant.

Purity is not net content

Net content describes the amount of material measured in a container or sample. Purity describes a relative analytical result. A vial can have a high HPLC area percentage while the measured mass differs from the label claim. A content result close to the label claim does not prove that all detected material is the intended peptide.

When reviewing net content, check the unit, measurement basis, sample type, method and whether the result is for one vial, a composite or a batch average. Do not convert a content number into a solution concentration without a defined preparation volume and method.

A practical comparison checklist

  • Product name and form: Does the report match the label, order and salt or blend form?
  • Lot or batch number: Does it match the physical vial or supplied batch record?
  • Report number: Is there a unique identifier rather than a generic image?
  • Identity method: Is the method and result clearly stated?
  • Purity method: Is the percentage tied to a chromatogram and method context?
  • Net content: Is the quantity reported separately from purity?
  • Laboratory and dates: Can the testing organization and analysis date be identified?
  • Scope: Are untested attributes clearly left unclaimed?

How to read a blend report

For a blend, an overall purity number may not show whether every listed component was identified and quantified. Look for component-by-component identity and content information, and confirm that the reported strength matches the product label. A COA for one ingredient is not evidence for the complete composition of a multi-component blend.

What a high number cannot tell you

Purity and identity results do not automatically establish sterility, endotoxin control, residual solvents, stability, biological potency, safety or effectiveness in humans or animals. Those conclusions require additional evidence. The correct interpretation is limited to the procedures and results actually listed in the report.

Use Newt’s batch records in the right order

Use Verify COA to locate the relevant Newt batch record first. Then compare the product name, lot number, report number, identity result, purity result and dates. If the record does not agree with the label or supplied documentation, contact Newt before treating the document as evidence.

For a step-by-step explanation of each COA section, see How to Read a Peptide COA. The two pages serve different purposes: the batch page helps locate the record; the guide explains how to interpret it.

Key takeaway

Purity and identity are two parts of a quality review, not two names for the same test. Read the identity evidence, the method-specific HPLC result and the net-content result separately, then confirm that all three refer to the correct batch.


Research-use notice: This article is provided for educational and laboratory reference only. It is not medical advice, a clinical protocol or a recommendation for human or veterinary use.

References

  1. FDA: Analytical Procedures and Methods Validation.
  2. ICH Q2(R2): Validation of Analytical Procedures.
  3. FDA Q6A Specifications.

Continue your review

Connect the guide to a batch record.

Use Newt’s COA library to locate available batch documentation, or browse the current research catalog.